MariaDB plc today announced the immediate availability of MariaDB Enterprise Platform 2026, positioning it as the definitive database platform for building next-generation intelligent applications.
Results of a phase 3 study suggest that marstacimab reduces bleeding events in patients with hemophilia A and B and without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback